2020-10-30

Meng, Jingwei, 1972-

CRISPR screening is a genetic loss-of-function approach that identifies the genes in a particular pool, such as DNA Damage Response (229 genes), Protein Kinases (746 genes), or Transcription factors (1580 genes), which are responsible for the phenotype of your interests. Chemical Genomics Core Facility (CGCF) researchers will assist you with experimental design, CRISPR library selection, high-throughput equipment training and usage. In this seminar, Jingwei Meng presents the usage of the current DNA Damage Response library in two recent screening projects and explains the existing standard protocols for such arrayed CRISPR screening at CGCF. The CGCF is currently collecting potential CRISPR-related projects and closely working with the IU Genome Editing Center (IUGEC) to bring researchers an integrated service suite of genome technology.

Indiana University School of Medicine; Indiana Clinical and Translational Sciences Institute

Ruth Lilly Medical Library

Educational

Chemogenomics; CRISPR (Genetics)

Cutting-Edge Drug Discovery Tools at the Chemical Genomics Core Facility

Ruth Lilly Medical Library